Asmanex

(mometasone furoate)

ApprovedSmall molecule

Mometasone furoate is used to reduce inflammation and relieve symptoms of asthma, allergies, and nasal congestion. It works by decreasing swelling and irritation in the airways and nasal passages.[2] Asmanex is currently approved and in use across 9 indications[4].[1]

Asmanex is one of 188 small molecule programs targeting Nasal congestion. It is currently in Approved.

Indications

Total Trials

Active Trials

187

Competitors

FDA Applications

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[4][1]

Indication

Nasal CongestionUnknown

Airway ObstructionUnknown

Skin DiseaseUnknown

Sleep DisorderActive, not recruiting

PhimosisActive, not recruiting

VitiligoActive, not recruiting

Chronic Rhinosinusitis With Nasal PolypsNot yet recruiting

Chronic RhinosinusitisCompleted

Head and Neck Squamous Cell CarcinomaUnknown status

Nasal CongestionPreclinical

Unknown

Airway ObstructionPreclinical

Unknown

Skin DiseasePreclinical

Unknown

Sleep DisorderPreclinical

Active, not recruiting

PhimosisApproved

Active, not recruiting

VitiligoApproved

Active, not recruiting

Chronic Rhinosinusitis With Nasal PolypsApproved

Not yet recruiting

Chronic RhinosinusitisApproved

Completed

Head and Neck Squamous Cell CarcinomaApproved

Unknown status

Competition

Competitive Landscape

116 competitors in Head and Neck Squamous Cell Carcinoma

#DrugCompanyPhaseTrials

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

35 2

Erbitux

IImclone

Phase 3

28 3

Asmanex

PPerrigo Company

Approved

1 4

Beyfortus

BeiGene

Phase 3

8 5

Imfinzi

AstraZeneca

Phase 3

6 6

Ibrance

Pfizer

Phase 3

4 7

Taxotere

AAvyxa

Phase 3

16 8

Tuoyi

CCoherus Oncology, Inc.

Phase 3

6 9

Theraplaza

BBiotech Pharmaceutical Co., Ltd.

Phase 3

4 10

Gilotrif

Boehringer Ingelheim

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Post-ApprovalNot yet recruiting

Alopecia Areata

NCT06399783

Phase 3Recruiting

Chronic Rhinosinusitis With Nasal Polyps

NCT06834360

Phase 3Recruiting

Chronic Rhinosinusitis With Nasal Polyps

NCT06834347

Clinical

Trials by Indication[1]

Seasonal Allergic Rhinitis18 trials

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

Completed· Novartis logo

Novartis·Phase 2·NCT00784732·44 enrolled

A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)

Completed·PPadagis LLC·Phase 3·NCT01673659·1,220 enrolled

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

Terminated· Novartis logo

Novartis·Phase 1·NCT05887843·38 enrolled

Show 15 more trials

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)

Completed·OOrganon and Co·Phase 3·NCT00732381·351 enrolled

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Completed·AAmneal Pharmaceuticals, LLC·Phase 3·NCT02125253·811 enrolled

Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)

Completed·OOrganon and Co·Phase 3·NCT03879772·679 enrolled

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)

Completed·OOrganon and Co·Phase 3·NCT00733005·324 enrolled

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)

Completed·OOrganon and Co·Phase 3·NCT00728416·333 enrolled

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)

Completed·OOrganon and Co·Phase 3·NCT03855189·345 enrolled

This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)

Completed·OOrganon and Co·Phase 4·NCT00491504·310 enrolled

Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

Completed·OOrganon and Co·Phase 3·NCT03882047·313 enrolled

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)

Completed·OOrganon and Co·Phase 3·NCT03855228·704 enrolled

Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)

Completed·OOrganon and Co·Phase 2·NCT00552110·707 enrolled

Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

Completed·UUniversity of Chicago·N/A·NCT00618332·40 enrolled

Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)

Completed·OOrganon and Co·Phase 3·NCT03861559·201 enrolled

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)

Completed·OOrganon and Co·Phase 3·NCT00468312·429 enrolled

Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)

Completed·OOrganon and Co·Phase 4·NCT00358527·401 enrolled

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)

Completed·OOrganon and Co·Phase 3·NCT00453063·426 enrolled

Allergic Rhinitis12 trials

Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)

Completed·OOrganon and Co·Phase 3·NCT01135134·333 enrolled

Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)

Completed·OOrganon and Co·Phase 4·NCT00834119·72 enrolled

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Completed·MMeda Pharmaceuticals·Phase 3·NCT00720382·703 enrolled

Show 9 more trials

A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)

Completed·OOrganon and Co·Phase 2·NCT00779545·455 enrolled

A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)

Completed·OOrganon and Co·Phase 3·NCT01165424·80 enrolled

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

Completed·OOrganon and Co·Phase 3·NCT00599027·51 enrolled

The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)

Completed·OOrganon and Co·Phase 4·NCT00359216·30 enrolled

Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)

Terminated·SSchering-Plough·Phase 4·NCT00491374

A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)

Completed·OOrganon and Co·Phase 3·NCT00732368·98 enrolled

Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis

Completed·—·Phase 1·NCT07016763·400 enrolled

Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis

Withdrawn·EEMS·Phase 3·NCT04670653

Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis

Completed·HHanlim Pharm. Co., Ltd.·Phase 3·NCT01470053·347 enrolled

Asthma5 trials

Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma

Completed· Novartis logo

Novartis·Phase 2·NCT01555151·739 enrolled

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma

Completed· Novartis logo

Novartis·Phase 3·NCT02554786·2,216 enrolled

Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma

Completed· Novartis logo

Novartis·Phase 2·NCT01609478·335 enrolled

Show 2 more trials

Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED)

Terminated·OOrganon and Co·Phase 4·NCT00687531·385 enrolled

Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma

Completed· Novartis logo

Novartis·Phase 2·NCT04589663·24 enrolled

Chronic Rhinosinusitis With Nasal Polyps5 trials

A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps

Not yet recruiting·—·Phase 4·NCT06801353·90 enrolled

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Recruiting· Sanofi logo

Sanofi·Phase 3·NCT06834360·210 enrolled

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Recruiting· Sanofi logo

Sanofi·Phase 3·NCT06834347·210 enrolled

Show 2 more trials

Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Completed·AAnaptysBio, Inc.·Phase 2·NCT03614923·105 enrolled

A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study

Enrolling by invitation· Sanofi logo

Sanofi·Phase 2·NCT06914908·71 enrolled

Hypertrophy4 trials

Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)

Completed·OOrganon and Co·Phase 3·NCT00552032·132 enrolled

Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED)

Withdrawn·OOrganon and Co·Phase 4·NCT00553891

Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)

Completed·OOrganon and Co·Phase 4·NCT01098071·34 enrolled

Show 1 more trial

Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy

Completed·GGuangzhou Women and Children's Medical Center·Phase 4·NCT02559440·240 enrolled

34 more indications

Nasal Polyps4 trials

Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps

Completed·IIntersect ENT·Phase 2/3·NCT01732536·100 enrolled

Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

Completed· Sanofi logo

Sanofi·Phase 3·NCT02898454·448 enrolled

Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)

Completed·OOrganon and Co·Phase 3·NCT00378378·127 enrolled

Show 1 more trial

A Randomised, Double-blind, Parallel Group PhIII Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab as an Add on to Maintenance Treatment in Adults With Severe Bilateral Nasal Polyps - SYNAPSE (StudY in NAsal Polyps Patients to Assess the Safety and Efficacy of Mepolizumab)

Completed· GSK logo

GSK·Phase 3·NCT03085797·414 enrolled

Sinusitis3 trials

Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)

Completed·OOrganon and Co·Phase 2·NCT00750750·981 enrolled

S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps

Completed·IIntersect ENT·Phase 3·NCT02291549·300 enrolled

Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)

Completed·OOrganon and Co·Phase 3·NCT00751075·981 enrolled

Nasal polyposis3 trials

Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)

Completed·OOrganon and Co·Phase 3·NCT00731185·162 enrolled

An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis

Completed· Sanofi logo

Sanofi·Phase 2·NCT01920893·60 enrolled

Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis

Completed·—·Phase 2·NCT04532736·41 enrolled

Effectiveness2 trials

Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate

Suspended·AAzidus Brasil·Phase 2·NCT01228656·40 enrolled

A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)

Completed·OOrganon and Co·Phase 3·NCT01386125·748 enrolled

Chronic Rhinosinusitis Without Nasal Polyps2 trials

A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Completed·IInsmed Incorporated·Phase 2·NCT06013241·288 enrolled

A Randomized, Double-blind, Placebo-controlled, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab in Participants With Inadequately Controlled Chronic Rhinosinusitis Without Nasal Polyps

Completed· Sanofi logo

Sanofi·Phase 2·NCT06691113·66 enrolled

Patient Preference2 trials

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)

Completed·OOrganon and Co·Phase 4·NCT00817050·100 enrolled

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)

Completed·OOrganon and Co·Phase 4·NCT00783458·100 enrolled

Breast Cancer1 trial

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Completed·NNorth Central Cancer Treatment Group·Phase 3·NCT00438659·176 enrolled

Resistance1 trial

An Open-label Study to Identify Molecular Markers of Steroid Resistance

Terminated·MMassachusetts General Hospital·Phase 4·NCT01616160·11 enrolled

Vitiligo1 trial

Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo

Unknown status·MMahidol University·Phase 4·NCT01333410·30 enrolled

Drug1 trial

Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)

Completed·OOrganon and Co··NCT00903721·3,806 enrolled

Psoriasis1 trial

Study of CRx-191 to Assess Activity in Plaque Psoriasis

Completed·ZZalicus·Phase 2·NCT00557739·20 enrolled

Sickle Cell Disease1 trial

Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease

Completed·JJeffrey Glassberg·Phase 2·NCT02061202·54 enrolled

Withdrawal1 trial

Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant

Completed·UUniversity Hospital, Ghent·Phase 4·NCT04898764·72 enrolled

Inflammation1 trial

Mometasone and Markers of Airway Inflammation

Completed·—·Phase 4·NCT00711165·12 enrolled

Bullous Pemphigoid1 trial

A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid

Terminated·AAlkahest, Inc.·Phase 2·NCT04499235·6 enrolled

Atopic Dermatitis1 trial

Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.

Unknown status·SSeanergy Dermatology Ltd.·Phase 1·NCT04615962·66 enrolled

Eosinophilic Esophagitis1 trial

Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.

Terminated·MMogens Bove·Phase 2·NCT02113267·40 enrolled

Clinical Trial1 trial

A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

Completed·EEurofarma Laboratorios S.A.·Phase 3·NCT01372865·364 enrolled

Efficacy and Safety1 trial

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Completed· Chong Kun Dang Pharmaceutical logo

Chong Kun Dang Pharmaceutical·Phase 3·NCT02498509·459 enrolled

Outcome1 trial

A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

Completed· GSK logo

GSK··NCT01199757·540 enrolled

ESS1 trial

A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers

Completed·ZZalicus·Phase 1·NCT00721331·20 enrolled

Alopecia Areata1 trial

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

Not yet recruiting·—·Phase 4·NCT06399783·54 enrolled

Obstructive Sleep Apnea1 trial

Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy

Withdrawn·—·Phase 3·NCT01671852

COVID-191 trial

Corticosteroid Nasal Spray in COVID-19 Anosmia

Completed·—·Phase 3·NCT04484493·100 enrolled

Head and Neck Squamous Cell Carcinoma1 trial

Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients

Unknown status·YYao Liao·Phase 4·NCT02495064·160 enrolled

Chronic Rhinosinusitis1 trial

Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery

Completed·FFirst Affiliated Hospital, Sun Yat-Sen University·Phase 4·NCT02110654·50 enrolled

Otitis Media With Effusion1 trial

The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study

Unknown status·MMuteea Mubark Salmen Bakuwiri·Phase 1·NCT03491098·60 enrolled

Sleep-disordered Breathing1 trial

Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children

Completed·MMurdoch Childrens Research Institute·Phase 4·NCT05382494·130 enrolled

Prevention1 trial

Dupilumab for Prevention of Recurrence of CRSwNP After ESS

Completed·—·Phase 4·NCT04596189·30 enrolled

Sleep Disorder1 trial

Multi-disciplinary Diagnosis and Treatment Process and Evaluation System for Children With Sleep Disordered Breathing and Malocclusion

Unknown status·—·N/A·NCT03451318·400 enrolled

Phimosis1 trial

Treatment of Phimosis With Topical Steroid Cream -Double-blind, Randomized, Placebo-controlled Study

Unknown status·UUniversity of Oulu·Phase 4·NCT01108198·100 enrolled

MPA1 trial

Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates

Completed·LLibbs Farmacêutica LTDA·Phase 4·NCT04271007·32 enrolled

Spinal Cord Injury1 trial

Acute and Chronic Effects of Inhaled Steroids on Pulmonary Function in Persons With Spinal Cord Injury

Unknown status·JJames J. Peters Veterans Affairs Medical Center·Phase 1·NCT01353599·50 enrolled

Unspecified6 trials

Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays

Unknown status·PPH&T S.p.A.·Phase 3·NCT01702103·360 enrolled

Long Term Safety Of GW685698X Via Nasal Biopsy

Completed· GSK logo

GSK·Phase 3·NCT00224523·125 enrolled

Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers

Completed· Novartis logo

Novartis·Phase 1·NCT00418509·24 enrolled

Show 3 more trials

Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)

Completed·OOrganon and Co·Phase 3·NCT00779740·102 enrolled

Phase I Study of Topical CRx-191 in Normal Healthy Volunteers

Completed·ZZalicus·Phase 1·NCT00544687·20 enrolled

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Completed· Teva logo

Teva·Phase 1/2·NCT01523236·800 enrolled

Regulatory

FDA Approval Timeline[5]

Apr 30, 1987

ELOCON

NDA NDA019543

May 6, 1987

ELOCON

NDA NDA019625

Mar 30, 1989

ELOCON

NDA NDA019796

Oct 1, 1997

NASONEX

NDA NDA020762

Feb 1, 2008

ASMANEX TWISTHALER

NDA NDA021067

Dec 8, 2017

SINUVA

NDA NDA209310

Aug 12, 2019

ASMANEX HFA

NDA NDA205641

Mar 17, 2022

NASONEX 24HR ALLERGY

NDA NDA215712

Sources

References

[1]
ClinicalTrials.gov — 93 trial records for mometasone furoate. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Asmanex drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — mometasone furoate compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for mometasone furoate. EMBL-EBI & Wellcome Sanger Institute.
[5]
OpenFDA — FDA approval records (NDA NDA215712). U.S. Food & Drug Administration.
[6]
SEC EDGAR — Perrigo Company company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Mechanism of Action: Glucocorticoid Receptor Agonist[3]
Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: PPerrigo Company

Asmanex

Status by Indication[4][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Seasonal Allergic Rhinitis18 trials

Allergic Rhinitis12 trials

Asthma5 trials

Chronic Rhinosinusitis With Nasal Polyps5 trials

Hypertrophy4 trials

Nasal Polyps4 trials

Sinusitis3 trials

Nasal polyposis3 trials

Effectiveness2 trials

Chronic Rhinosinusitis Without Nasal Polyps2 trials

Patient Preference2 trials

Breast Cancer1 trial

Resistance1 trial

Vitiligo1 trial

Drug1 trial

Psoriasis1 trial

Sickle Cell Disease1 trial

Withdrawal1 trial

Inflammation1 trial

Bullous Pemphigoid1 trial

Atopic Dermatitis1 trial

Eosinophilic Esophagitis1 trial

Clinical Trial1 trial

Efficacy and Safety1 trial

Outcome1 trial

ESS1 trial

Alopecia Areata1 trial

Obstructive Sleep Apnea1 trial

COVID-191 trial

Head and Neck Squamous Cell Carcinoma1 trial

Chronic Rhinosinusitis1 trial

Otitis Media With Effusion1 trial

Sleep-disordered Breathing1 trial

Prevention1 trial

Sleep Disorder1 trial

Phimosis1 trial

MPA1 trial

Spinal Cord Injury1 trial

Unspecified6 trials

FDA Approval Timeline[5]

References

Drug Info

Quick Facts

Related News